- Home
- ROIV vs PRI Comparison
ROIV vs PRI Comparison
Compare ROIV & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PRI
- Stock Information
- Founded
- ROIV 2014
- PRI 1927
- Country
- ROIV United Kingdom
- PRI United States
- Employees
- ROIV N/A
- PRI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PRI Life Insurance
- Sector
- ROIV Health Care
- PRI Finance
- Exchange
- ROIV Nasdaq
- PRI Nasdaq
- Market Cap
- ROIV 7.8B
- PRI 8.5B
- IPO Year
- ROIV N/A
- PRI N/A
- Fundamental
- Price
- ROIV $11.85
- PRI $261.55
- Analyst Decision
- ROIV Buy
- PRI Buy
- Analyst Count
- ROIV 3
- PRI 7
- Target Price
- ROIV $15.25
- PRI $313.00
- AVG Volume (30 Days)
- ROIV 4.6M
- PRI 164.8K
- Earning Date
- ROIV 08-11-2025
- PRI 08-06-2025
- Dividend Yield
- ROIV N/A
- PRI 1.59%
- EPS Growth
- ROIV N/A
- PRI 61.36
- EPS
- ROIV N/A
- PRI 20.26
- Revenue
- ROIV $23,233,000.00
- PRI $3,220,913,000.00
- Revenue This Year
- ROIV $3.28
- PRI $2.89
- Revenue Next Year
- ROIV $156.84
- PRI $4.93
- P/E Ratio
- ROIV N/A
- PRI $12.35
- Revenue Growth
- ROIV N/A
- PRI 7.56
- 52 Week Low
- ROIV $8.73
- PRI $230.98
- 52 Week High
- ROIV $13.06
- PRI $307.91
- Technical
- Relative Strength Index (RSI)
- ROIV 58.16
- PRI 47.21
- Support Level
- ROIV $10.90
- PRI $255.46
- Resistance Level
- ROIV $12.12
- PRI $265.33
- Average True Range (ATR)
- ROIV 0.30
- PRI 5.80
- MACD
- ROIV 0.03
- PRI 0.06
- Stochastic Oscillator
- ROIV 77.87
- PRI 36.12
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PRI Primerica Inc.
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.